Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection

被引：0
|
作者：
Barnabas, R., V
Brown, E. R.
Bershteyn, A.
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 03期
关键词：
D O I：
10.7326/P20-0015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：I16 / I16
页数：1
相关论文
共 50 条
  • [21] Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
    Saleh, Moussa
    Gabriels, James
    Chang, David
    Kim, Beom Soo
    Mansoor, Amtul
    Mahmood, Eitezaz
    Makker, Parth
    Ismail, Haisam
    Goldner, Bruce
    Willner, Jonathan
    Beldner, Stuart
    Mitra, Raman
    John, Roy
    Chinitz, Jason
    Skipitaris, Nicholas
    Mountantonakis, Stavros
    Epstein, Laurence M.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2020, 13 (06): : E008662
  • [22] Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
    Rosenke, Kyle
    Jarvis, Michael A.
    Feldmann, Friederike
    Schwarz, Benjamin
    Okumura, Atsushi
    Lovaglio, Jamie
    Saturday, Greg
    Hanley, Patrick W.
    Meade-White, Kimberly
    Williamson, Brandi N.
    Hansen, Frederick
    Perez-Perez, Lizette
    Leventhal, Shanna
    Tang-Huau, Tsing-Lee
    Callison, Julie
    Haddock, Elaine
    Stromberg, Kaitlin A.
    Scott, Dana
    Sewell, Graham
    Bosio, Catharine M.
    Hawman, David
    de Wit, Emmie
    Feldmann, Heinz
    [J]. JCI INSIGHT, 2020, 5 (23)
  • [23] Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
    Juurlink, David N.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (17) : E450 - E453
  • [24] Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection
    Klimke, A.
    Hefner, G.
    Will, B.
    Voss, U.
    [J]. MEDICAL HYPOTHESES, 2020, 142
  • [25] Admission QT interval and hydroxychloroquine treatment in SARS-CoV-2 patients
    De Gregorio, Cesare
    Zappia, Luca
    Laterra, Giulia
    Firetto, Giorgio
    Fichera, NunzioAntonio G.
    Versace, Antonio G.
    Luzza, Francesco
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N68 - N68
  • [26] Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
    Luigi Moschini
    Marco Loffi
    Valentina Regazzoni
    Giuseppe Di Tano
    Elisa Gherbesi
    Gian Battista Danzi
    [J]. Heart and Vessels, 2021, 36 : 115 - 120
  • [27] Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
    Cobos-Campos, R.
    Apinaniza, A.
    Parraza, N.
    Cordero, J.
    Garcia, S.
    Orruno, E.
    [J]. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2021, 69 (04)
  • [28] Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection
    Bruzzesi, Elena
    Ranzenigo, Martina
    Castagna, Antonella
    Spagnuolo, Vincenzo
    [J]. NEW MICROBIOLOGICA, 2021, 44 (03): : 135 - 144
  • [29] Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis
    Oscanoa, Teodoro J.
    Vidal, Xavier
    Kanters, Jorgen K.
    Romero-Ortuno, Roman
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (06)
  • [30] Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
    Moschini, Luigi
    Loffi, Marco
    Regazzoni, Valentina
    Di Tano, Giuseppe
    Gherbesi, Elisa
    Danzi, Gian Battista
    [J]. HEART AND VESSELS, 2021, 36 (01) : 115 - 120
12345